| REVIEW ARTICLE |
|
| Year : 2017 | Volume
: 4
| Issue : 4 | Page : 323-329 |
|
|
Role of systemic antibiotics in preventing epidermal growth factor receptor: Tyrosine kinase inhibitors-induced skin toxicities
Philomena Charlotte Dsouza BSN, RN 1, Shiyam Kumar2
1 Directorate of Nursing, Sultan Qaboos University Hospital, Muscat, Oman
2 Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman
Correspondence Address:
Philomena Charlotte Dsouza
C/O Nursing Directorate, Sultan Qaboos University Hospital, Muscat
Oman
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/apjon.apjon_28_17
|
|
|
The epidermal growth factor receptor (EGFR) is actively involved in the growth of multiple tumor types and has been found as an effective treatment target in various solid cancers, for example, lung cancer and head and neck cancer. Of effective drugs which target and inhibit EGFR functions, tyrosine kinase inhibitors have shown promising results, albeit at a cost of side effects, skin toxicity being the most common. This article provides an evidence-based strategy to oncology nurse practitioners in dealing with such toxicity. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
